ClinicalTrials.gg
Not yet recruitingNCT02639897Updated Jun 26, 2026

Evaluation of Functional Dimensions of Macintosh Laryngoscope Blade During Direct Laryngoscopy in Patients With Normal Mouth Opening

An observational study in Submucous Fibrosis, sponsored by Sir Ganga Ram Hospital. Not yet recruiting at 1 site in India. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by Sir Ganga Ram Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
20 Years to 65 Years
Sex
All
01

Study summary

Direct laryngoscopy and intubation is an essential initial aspect of airway access during general anesthesia. To perform the procedure effectively, it requires adequate mouth opening, head and neck movement, and a normal temporo-mandibular joint mobility. Any issue with the above three results in a compromised upper airway at the outset and the condition is known as anticipated difficult airway, i.e. an airway that is difficult to access with conventional laryngoscopy and intubation methods. To overcome the difficulty, either one has to resort to newer advanced technique and equipment or the available conventional technique needs to be refined and modified to suit the requirement. While the former requires extraordinary expertise and finances, an option difficult to achieve in developing countries; the latter warrants focused interest to develop alternative approach with the same set of equipments.

Since submucous fibrosis and the associated restricted mouth opening have taken the proposition of an epidemic owing to widespread use of betel nut and tobacco; these patients, when requiring surgery, are difficult candidates for GA and airway control. The fact that, when they arrive as pre-surgical candidates, they have variable degree of mouth opening restriction, which if approached with a strategy, may be amenable to conventional control of airway. If investigators paint all the patients with mouth restriction as difficult airway, it will result in uncalled surgical, economic, health system and psychological burden. Therefore, it is prudent to undertake research relating to refinement of airway access techniques with the easily available, cheap and user- friendly equipment (conventional laryngoscope), such that a proportion of above stated burden can be reduced.

In view of the above, investigators plan to undertake a study to enhance our working knowledge with a conventional laryngoscope (Macintosh) to facilitate ways to control the airway difficulty secondary to mouth opening restriction. Investigators believe that the prospective knowledge thus generated would help us identify whether there is a feasibility of conventional airway management or an alternative advanced access technique is needed in the first place. This will prevent undue cancellations, delayed surgeries, and patient morbidity.

Read the detailed description

Upper airway access is one of the essential components of general anaesthesia, and more often than not, it is gained by direct laryngoscopy followed by tracheal intubation. While direct laryngoscopy depends on laryngoscope blade design and the anesthetists' skill set, the ease of tracheal intubation is influenced by the line-of-view to the glottis gained by the laryngoscopy maneuver. In patients with normal mouth opening (≥4.0 cm), the act of conventional airway access is not difficult given that the neck extension and the TMJ joint mobility is within normal limits. Conversely, it becomes difficult in patients who have mouth opening restriction, and hence they are adjudicated as 'anticipated difficult airway' (ADA). The ADA, attracts several issues that, not uncommonly, converges on to time inefficiency, heightened equipment cost, operator anxiety, and unfortunately, patient morbidity. There are many causes of restricted mouth opening, defined technically as reduced inter-incisor distance (IID) including trauma, TMJ movement limitation, intra/extra-oral pathology resulting in pain, or the most common pathology in the Indian subcontinent, oral submucosal fibrosis (SMF). While the pathology itself is a forerunner of oral mitosis, it is the associated restricted mouth opening component that put conventional airway access efforts of the anaesthesiologist in spot, and consequently, a whole, sometimes unnecessary rigmarole has to be activated under the heading of 'advanced approach to ADA'.

Oral submucous fibrosis (SMF) is a well-recognized, potentially malignant progressive condition afflicting the oral cavity that is characterised by a reduced mouth opening. The reduction in mouth opening occurs due a vertical reorientation of collagen fibrils that are normally haphazardly arranged. Of the currently available multiple classifications to identify disease stage/severity, the functional classification based on the inter-incisor distance (IID) seems to be most relevant.

IID forms an important component of airway examination and a value of less than 3-cm is suggestive of difficulty in airway management. However, despite the above, SMF is largely unrecognized as a cause of airway difficulty, and even when recognized, no set protocol is available to ensure (as far as possible) a favourable outcome in terms of least morbidity to the patient, and stress to the anaesthesiology team in question.

Need Assessment for the Study Generally, in a tertiary level centre, with all facilities at hand, cases with a reduced IID are normally tackled using a fiberoptic bronchoscope guided tracheal intubation. However, in India, the burden of this disease lies to a great extent in rural/suburban settings where access to a fiberoptic bronchoscope is unlikely. As a result these cases are referred to 'higher' centres for management. This imposes undue burden (logistics/ financial) onto patients and their families. Hence, there is a great need for anaesthesiologists working at the primary/secondary level healthcare set up to get oriented to this problem and be able to manage it with conventional options (direct laryngoscopy \& intubation) available to them.

Scientific Contention Direct laryngoscopy remains the foremost among the various techniques available to access the upper airway and the Macintosh blade has been the most preferred blade type. In order to improve direct laryngoscopy, many modifications of blade design have been tested/ compared with the Macintosh blade, but apparently, the clarity as to which laryngoscope blade is most suited for a given airway remains low. For the majority of practicing anaesthesiologists, the availability of different laryngoscope designs has only increased the hit-and-trial option for laryngoscopy.

Since the time it was first introduced, the Macintosh blade (size 1, 2, 3, 4, and 5) has weathered many newer laryngoscope blade designs and stood by our side with consistent/optimal performance. Per se, from a technical standpoint, although shaped the same, various sizes of the Macintosh blade are not exactly similar, the discrepancy becomes obvious when comparing sizes 1, 2 with 3 \& 4. Unfortunately, investigators are still unclear as to how design characteristics and the various sizes of the Macintosh blade impact the process of direct laryngoscopy. Generally, the selection of laryngoscope blade (type and sizes) is largely a function of individual experience and preferences. The absence of predefined parameters for the selection of the most appropriate laryngoscope blade for a given airway remains arbitrary. Apparently, an anaesthesiologist will be able to intubate an adult trachea with any of the laryngoscope blade, however, blade type and size selection assumes significance in the presence of a difficult airway.

The three factors which influence successful direct laryngoscopy performance are:

i) The ability to place the laryngoscope blade tip in vallecular recess and engage the hyoid bone. This requires an adequate length of the blade to be introduced orally to reach the vallecula (transition space between base of the tongue and the epiglottis) position.

ii) The ability to displace the tongue aside for clear view to the glottic-epiglottic region iii) Achieving a clear line-of-sight to the glottis-opening. To ensure that the tip of the laryngoscope blade engages the hyoid by placement in the vallecula, an adequate blade length must be inserted into the oral cavity. Normally, this is easily achieved. However, when faced with a situation involving reduced mouth opening/inter-incisor distance (e.g.as in case of SMF), the length of blade that can be inserted into the oral cavity (functional length) becomes a function of the width of the blade's flange at the incisor point. Thus the size of the flange, corresponding to the width of the blade that must be accommodated in the oral cavity assumes particular significance in patients with reduced inter-incisor gap. Typically, for the Macintosh blade's curved design confers different length to its flange's glossal (concave) and the palatal (convex) surface, the functional width of its flange increases from the tip towards the heel [Figure]. Based on the degree of mouth opening restriction and the available IID (in cm), during preoperative evaluation, one can predict and plan how long a Macintosh blade length will be required and what size of the blade would suffice to be placed orally through the available IID.

Hypothesis Development Marks et al, utilized an x-ray based method to devise a method to evaluate laryngoscope blade design during active laryngoscopy procedure. Technically, they found that Macintosh sizes 3 and 4 have a more refined blade design that provides greater degree of forward space enhancement (FSE, allows greater mandibular space for the tongue to be moved into) than other conventional blades (Miller, Soper, etc.). This FSE-effect gets further magnified with increase in functional length of the blade (the length of the blade inside the oral cavity during active laryngoscopy).

Their elaborate work addressed the performance of the laryngoscope blade (size, type) selection in a theoretical setting. The information gleaned from their assessment offered valuable suggestions on optimal blade position during direct laryngoscopy and included:

i) Mandibular space 'encroachment/enhancement' with the use of different blade types/sizes, and ii) 'Line-of-vision' (view to the glottis) versus 'mandibular space restriction' (space for tongue displacement during laryngoscopy).

However, still, the clinical feasibility of knowledge thus gained from performance assessment facilitated by x-ray/fluoroscopy is difficult to translate into routine clinical practice.

As the investigator prepares to take the conventional direct laryngoscopy process into difficult airway situations where the primary difficulty is due to reduced mouth opening, there is a need to convert theoretical knowledge into clinical suggestions. Investigators thus contend that unless they get accustomed with greater clarity on the use of routine equipments, and analyse their practical feasibility in difficult situations, the element of randomness and subjectivity will continue to be a setback.

02

Conditions studied

  • Submucous Fibrosis
03

In context

Lead sponsor

Sir Ganga Ram Hospital is the lead sponsor of 30 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients scheduled for surgery under general anaesthesia with airway control by direct laryngoscopy and tracheal intubation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Consenting adults
  2. Both gender
  3. Age: 20-65 years
  4. Normal preoperative upper airway evaluation and without the presence of anticipated airway access difficulty
  5. Patients scheduled for surgery under general anaesthesia with airway control by direct laryngoscopy and tracheal intubation

Exclusion criteria

Exclusion Criteria:

  1. Patient refusal
  2. Anticipated airway access difficulty
  3. Edentulous patients
  4. Patients with dental problem (missing tooth, overlap, cosmetic treatment)
  5. Vulnerable Patients: High risk situation, major surgery, extremes of age, obstetric patients
  6. Previously difficult airway
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • OtherDirect Laryngoscopy

    Tracheal intubation with direct laryngoscopy using Macintosh laryngoscope blade

06

What researchers measure

Primary outcomes

  1. Macintosh Blade Length Measurement (in centimeters)

    Length of Macintosh blade size 3 and 4 as such (static) and during active direct laryngoscopy (active).

    Time frame: 0 to 5-minutes

  2. Macintosh Blade Width Measurement (in centimeters)

    Width of Macintosh blade size 3 and 4 as such (static) and during active direct laryngoscopy (active).

    Time frame: 0 to 5-minutes

  3. Inter-incisor Angle on Macintosh Blade Contact Point (in degrees)

    The angle formed by the line between the two contact points, viz. a point formed by upper incisor contact of upper flange curve (convex) of the Macintosh laryngoscope blade, and a point of contact between the lower incisor contact with lower flange curve (concave curve) of the Macintosh laryngoscope blade. The line formed by joining these two contact points with the baseline of the laryngoscope will form an angle. This angle will be noted as functional separation of eugnathic, retrognathic or prognathic maxilo-mandibular orientation

    Time frame: 0 to 5-minutes

Secondary outcomes

  1. Upper Airway Measurements (in centimeters)

    Mento-hyoid, mento-thyroid distance, and the length of sub-mandibular triangle perpendicular

    Time frame: 0 to 5-minutes

  2. Correlation Assessment

    The functional laryngoscope length will be tested for correlation with the linear neck (Mento-hyoid distance, menlo-thyroid distance ) and mandibular distances (perpendicular to sub-mandibular triangle) and the most consistent one will be taken

    Time frame: 0 to 5-minutes

07

Study locations

1 site
  • Sir Ganga Ram Hospital
    New Delhi, 110060, India
    • Amitabh Dutta, MD · Contactduttaamitabh@yahoo.co.in · +919810848064
    • Nitin Sethi, DNB · Contactnitinsethi77@yahoo.co.in · +919717494498
    • Amitabh Dutta, MD · Principal investigator
    • Ameya Pappu, MBBS · Principal investigator
    • Nitin Sethi, DNB · Principal investigator
    • Prabhat Choudhary, MD · Sub investigator
    • Manish Gupta, MD · Sub investigator
    • Savitar Malhotra, MD · Sub investigator
    • Bhuwan C Panday, MD · Sub investigator
    • Shvet Mahajan, DA, DNB · Sub investigator
    • Jayashree Sood, MD, FFARCS · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Jun 2030, 44 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2015
First posted
Dec 28, 2015
StartEst.
Oct 2026
Primary completionEst.
Jun 2030
CompletionEst.
Jul 2030
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02639897
Lead sponsor
Sir Ganga Ram Hospital
Responsible party
Nitin Sethi, DNB (Consultant, Sir Ganga Ram Hospital) — Principal investigator
First posted
Dec 28, 2015
Start date
Oct 2026 (estimated)
Primary completion
Jun 2030 (estimated)
Completion
Jul 2030 (estimated)
Last update
Jun 26, 2026

Study contacts

Nitin Sethi, DNB
Contact
nitinsethi77@yahoo.co.in
00919717494498
Amitabh Dutta, MD
Contact
duttaamitabh@yahoo.co.in
00919810848064
Amitabh Dutta, MD
study director · Sir Ganga Ram Hospital, New Delhi, INDIA
Ameya Pappu, MBBS
study chair · Sir Ganga Ram Hospital, New Delhi, INDIA
Nitin Sethi, DNB
principal investigator · Sir Ganga Ram Hospital, New Delhi, INDIA

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion